Mesoporous polydopamine nanoparticles are nanoscale particles (typically 50–300 nm in diameter) composed of self-polymerized dopamine, featuring a highly ordered pore structure with pore diameters in the 2–50 nm range. This mesoporosity creates a high specific surface area and large pore volume, enabling efficient loading of therapeutic payloads.

Key Properties of MPDA NPs

The Synthesis of MPDA NPs

The most common synthesis approach for MPDA NPs is template-based synthesis: surfactants such as F127 or Pluronic copolymers self-assemble into micelles forming the mesoporous template; dopamine hydrochloride is then added under weak alkaline conditions (Tris buffer, pH 8.5), triggering oxidative self-polymerization around the template; the surfactant is subsequently extracted through repeated washing with ethanol or acid leaching, leaving a mesoporous PDA framework; and the resulting nanoparticles are collected by centrifugation and thoroughly washed. A significant advance was the development of interfacial mesopore assembly (IMA) , enabling direct synthesis of MPDA NPs with ultra-large pores (up to 13 nm) using anisotropic F127 micelles as templates. In the self-template method, PEG-amine is added to dopamine before polymerization, acting as both a reducing agent and a stabilizer to generate pores and prevent aggregation—producing MPDA NPs with high drug loading (e.g., 104 % DOX loading). Finally, by adjusting synthesis parameters such as temperature, pH, dopamine and template concentrations, and reaction time, researchers can precisely control particle size, pore size, and surface properties.

Biomedical Applications

MPDA NPs are powerful photothermal agents; the mesoporous structure enhances NIR absorption and conversion efficiency (typically 30–50 %, with temperature rises of 40–50 °C under 808 nm laser irradiation), enabling effective photothermal therapy of breast, liver, and colon cancers. The high drug loading capacity of MPDA NPs further enables synergistic chemo-photothermal therapy, where chemotherapeutics such as DOX, cisplatin, or paclitaxel are loaded into the mesopores and released upon NIR-triggered photothermal heating; DOX-loaded MPDA NPs have effectively inhibited tumor growth in vivo, and PDA-coated core–shell platforms have improved drug delivery. MPDA NPs also enable stimuli-responsive drug delivery through pH-, NIR-, or dual-responsive release mechanisms—protonation/deprotonation changes in acidic tumor environments accelerate drug release, while photothermal heating disrupts drug–PDA interactions. In immunotherapy, MPDA NPs serve as immunological adjuvants by loading ICD inducers, modulating the tumor immune microenvironment with checkpoint inhibitors, or acting as nanovaccines. Their intrinsic photoacoustic properties support photoacoustic imaging, while functionalization with fluorescent dyes, gadolinium/iron (for MRI contrast), or radiolabels enables fluorescence, MRI, and PET imaging. Their small size and biocompatibility also allow blood-brain barrier penetration, making them promising for brain disease treatment. Finally, MPDA NPs serve as excellent theranostic platforms, integrating photothermal therapy, chemotherapy, and multiple imaging modalities into a single nanoparticle for comprehensive cancer management.

Environmental Applications

Beyond biomedicine, MPDA NPs have found applications in environmental remediation:

Pollutant adsorption: High surface area enables efficient adsorption of heavy metal ions (e.g., Cu2+, Pb2+) and organic dyes

Photocatalytic degradation: MPDA NPs can degrade organic pollutants under NIR light

Water treatment: MPDA-based platforms show high adsorption capacities for environmental pollutants

How to Buy?

BOT Bioparticles offers high-quality mesoporous polydopamine nanoparticles (MPDA NPs) with precisely controlled particle sizes, pore structures, and surface properties to meet diverse research and application needs. Our products exhibit excellent colloidal stability, strong near-infrared absorption, and high photothermal conversion efficiency, making them ideal platforms for photothermal therapy, drug delivery, bioimaging, and theranostic applications. We provide custom synthesis services to tailor particle size, pore architecture, and surface chemistry to your specific experimental requirements. Our technical team is also available to assist with particle design, synthesis optimization, and application development, ensuring you receive a solution that integrates seamlessly with your research or development workflow.